UNITY Biotechnology, Inc. Completes $55 Million Series C Financing

Proceeds to Support Advancement of Pipeline into Clinical Studies SAN FRANCISCO, March 19, 2018 -- (Healthcare Sales & Marketing Network) -- UNITY Biotechnology, Inc. ("UNITY"), a privately held biotechnology company developing therapeutics t... Biopharmaceuticals, Venture Capital UNITY Biotechnology, senolytic medicine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news